FireEye, PVH, Five Below Stock Upgraded --> FireEye, PVH, Five Below Stock Upgraded
U-shaped NYC skyscraper would be 'longest in the world'
Ford Motor Posted Forecast for First-Quarter
The Walgreens Boots Alliance Inc (WBA) Rating Reiterated by Deutsche Bank AG
Disney CEO Bob Iger gets contact extension to July 2019
Bristol-Myers Squibb Co (BMY) Shares Sold by TCW Group Inc
20 March 2017, 06:13 | Kelvin Horton
Image source Bristol Myers Squibb
Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings results on Thursday, January 26th. Mn Services Vermogensbeheer B.V. now owns 43,185 shares of the biopharmaceutical company's stock worth $2,329,000 after buying an additional 812 shares in the last quarter. Ticker has price to earnings growth of 1.48, which is a valuation metric for determining relative trade-off among price of a stock. After this transaction, the insider's stake stands at 445,299 shares, with a market value of $25319701. Bristol-Myers Squibb's dividend payout ratio is 58.87%.
Jefferies analysts provided their view on Bristol-Myers Squibb Company (NYSE:BMY) recently. Neuberger Berman Group LLC now owns 5,738,782 shares of the biopharmaceutical company's stock worth $309,435,000 after buying an additional 208,546 shares in the last quarter. Nationwide Fund Advisors increased its stake in shares of Bristol-Myers Squibb by 31.1% in the second quarter. The institutional investor owned 148,666 shares of the biopharmaceutical company's stock after selling 12,834 shares during the period.
Receive Bristol-Myers Squibb Company News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol-Myers Squibb Company with MarketBeat.com's FREE daily email newsletter.
The stock volatility for week was 1.35% while for month was 2.03%.The stock, as of last close, traded 24.45% to its 52 week low and was changed -24.74% from its 52 week high. The 52-week high of Bristol-Myers Squibb Company (NYSE:BMY) is $77.12 and the 52-week low is $46.01.
Bristol-Myers Squibb Company has 1 year price target of $55.37.
Bristol-Myers Squibb Company (NYSE:BMY) has scored 2.27 rating. Presently Bristol-Myers Squibb Company (BMY) received consensus rating of " Overweight " from analysts, according to FactSet data. The company earned $5.24 billion during the quarter, compared to analyst estimates of $5.14 billion. Equities research analysts predict that Bristol-Myers Squibb Company will post $2.81 earnings per share for the current year. For the next 5 years, Bristol-Myers Squibb Company is expecting Growth of 14.47% per annum, whereas in the past 5 years the growth was 5.73% per annum.
The earnings of Duke Energy Corporation (DUK) are forecasted by the analysts to move at $1.08 in current quarter, from $1.13 a year-ago quarter. The difference between actual earnings and estimated earnings was $0.04 per share. This represents a $1.56 dividend on an annualized basis and a yield of 2.80%. Finally, Cowen and Company set a $85.00 price target on Bristol-Myers Squibb and gave the company a "buy" rating in a research note on Thursday, December 1st.
"Welch Investments LLC Invests $119,000 in Bristol-Myers Squibb Co (BMY)" was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and global trademark and copyright laws.
A number of research analysts have weighed in on the company. Zacks Investment Research upgraded shares of Bristol-Myers Squibb Company from a "hold" rating to a "buy" rating and set a $63.00 target price for the company in a report on Wednesday, December 14th.
While executing this assessment, the financial tools like Balance Sheet play a vital role. Vetr raised Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating and set a $64.78 price target on the stock in a research note on Wednesday, January 11th. The last session's volume of 2.62 million shares was lower than its average volume of 4.88 million shares. Following the purchase, the director now owns 12,000 shares in the company, valued at $681,240. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
10/13/2016 - Bristol-Myers Squibb Company was downgraded to "buy" by analysts at Goldman Sachs. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics.
Huawei announce P10 lite
The P10 Lite has been largely kept similar to the flagship smartphone with its 2.5D curved glass on the front and a metal frame. The dual SIM smartphone measures 146.50 x 72.00 x 7.20 cm (height x width x thickness) and weigh 142.00 grams.
Kendall Jenner robbed of 200k worth of jewellery
They dragged me out to the hallway on top of the stairs. "It's definitely looking like it was someone she knew". U.S. model Kendall Jenner contacted the police after jewellery was stolen from her home, according to reports.